Impact of revised antiretroviral treatment on the immunological, virological and clinical parameters among people infected with HIV

---

Original Article

Author Details : Jaya Lalwani*, Camilla Rodrigues, Rajeev Soma

Volume : 5, Issue : 3, Year : 2018

Article Page : 374-377

https://doi.org/10.18231/2394-5478.2018.0078

Suggest article by email

Get Permission

---

Abstract

Introduction: In resource-limited countries like India, where resistance testing is often not available, an accurate treatment history can guide doctors in quantifying suboptimal drug exposure and thus anticipate drug resistance
Materials and Methods: In the present longitudinal study, a total of 75 patients failing antiretroviral therapy; the effective drug exposure was calculated after taking into account the adherence, appropriateness of prescriptions, and pharmacokinetic interactions. Treatment was modified and patients were followed up.
Results: Of the total 75 patients included in the study; 69 (92.0%), 63 (84.0%) and 42 (56.0%) patients had virological, immunological and clinical failure respectively. Suspected reasons for antiretroviral drug failure were non-adherence in 48 (64.0%), improper prescriptions in 12(16.0%) and drug interactions in 12 (16.0%). We observed that following treatment change, CD4 count increased by a mean of 127 cells/?l and 33 (44.0%) patients had fully suppressed viral loads.
Conclusion: Our results show that empirical treatment changes based on a comprehensive drug history, followed by good adherence lead to good treatment outcomes in patients showing one or other evidence of drug resistance.

Keywords: HIV, AIDS, Drug-resistance, Antiretroviral.

How to cite : Lalwani J , Rodrigues C, Soma R, Impact of revised antiretroviral treatment on the immunological, virological and clinical parameters among people infected with HIV. Indian J Microbiol Res 2018;5(3):374-377

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.